Skip to main content

Advertisement

Retraction Note: effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women

The original article was published in BMC Research Notes 2014 7:52

Retraction

This article [1] has been retracted by the editors of BMC Research Notes because, contrary to the statement in the manuscript, Moi University Institutional Research and Ethics Committee (IREC) has confirmed that ethics approval was not obtained to conduct this study. In addition, the authors did not have permission to use data from the DREAM program.

References

  1. 1.

    Ngemu EK, Khayeka–Wandabwa C, Kweka EJ, Choge JK, Anino E, Oyoo-Okoth E: Effectiveness of option B highly active antiretroviral therapy (HAART) prevention of mother-to-child transmission (PMTCT) in pregnant HIV women. BMC Res Notes. 2014, 7: 52-10.1186/1756-0500-7-52.

Download references

Author information

Correspondence to Eliningaya J Kweka.

Additional information

The online version of the original article can be found at 10.1186/1756-0500-7-52

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark